FOXO Technologies(us:FOXO)

0.1260

+2.11%

Updated on 2025-03-31

Open:0.1229
Close:0.1260
High:0.1272
Low:0.1137
Prev Close:0.1234
Volume:949965.00
Turnover:115180.60
Turnover Ratio:4.03%
Shares:23.57M
MarketCap:2.97M
DateTotalTotal SharesTotal RatioNewIncreasedDecreased
2024-06-30163094632.74%425
2024-03-31143865274.32%322
2023-12-31193486544.56%269
2023-09-30171419900.24%242
2023-06-301712999492.80%243
2023-03-311910605873.87%926
2022-12-31156502572.36%608
2022-09-3038409212912.39%7229
dateorgNametotalratiochangeShareschangeRatio
2024-03-31Cantor Fitzgerald, L. P.1904762.13%0
2024-03-31Clear Street Llc500000.56%50000
2024-03-31Corbin Capital Partners, L.P.274800.31%0
2024-03-31Geode Capital Management, Llc248640.28%0
2024-03-31Vanguard Group Inc242380.27%0
2024-03-31Virtu Financial Llc235630.26%23563
2024-03-31State Street Corp200300.22%0
2024-03-31Jane Street Group, Llc120930.14%12093
2024-03-31Atalaya Capital Management Lp117780.13%0
2024-03-31Tower Research Capital Llc (Trc)17500.02%19012.18%

About

FOXO Technologies, Inc. develops genetic sequencing technology, artificial intelligence and bioinformatics tools. It operates through the FOXO Labs and FOXO Life segments. The FOXO Labs segment refers to the research and development and is commercializing proprietary epigenetic biomarker technology. The FOXO Life segment is involved in combining life insurance with a dynamic molecular health and wellness platform. The company was founded in 2020 and is headquartered in Minneapolis, MN.
Address:729 North Washington Avenue,Suite 600

Market Movers